Discontinued — last reported Q4 '24
U.S. Pharmaceutical — Total operating profit
McKesson U.S. Pharmaceutical — Total operating profit decreased by 20.6% to $854.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 178.2%, from $307.00M to $854.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates improved operational efficiency, higher volume throughput, or better pricing power within the pharmaceutical supply chain, while a decrease may signal rising operating costs, competitive pricing pressure, or shifts in product mix.
Detailed definition
This metric represents the total operating profit generated by the U.S. Pharmaceutical segment, reflecting the earnings...
Peer comparison
Similar to operating income metrics reported by other major pharmaceutical wholesalers and healthcare distributors, which are typically evaluated based on operating margin expansion and segment-level contribution to total corporate earnings.
mck_segment_u_s_pharmaceutical_total_operating_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $682.00M | $760.00M | $744.00M | $696.00M | $896.00M | $850.00M | $827.00M | $593.00M | $307.00M | $781.00M | $1.08B | $854.00M |
| QoQ Change | — | +11.4% | -2.1% | -6.5% | +28.7% | -5.1% | -2.7% | -28.3% | -48.2% | +154.4% | +37.6% | -20.6% |
| YoY Change | — | — | — | +2.1% | +17.9% | +14.2% | +18.8% | -33.8% | -63.9% | -5.6% | +81.3% | +178.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's u.s. pharmaceutical — total operating profit?
- McKesson (MCK) reported u.s. pharmaceutical — total operating profit of $854.00M in Q4 2024.
- How has McKesson's u.s. pharmaceutical — total operating profit changed year-over-year?
- McKesson's u.s. pharmaceutical — total operating profit increased by 178.2% year-over-year, from $307.00M to $854.00M.
- What does u.s. pharmaceutical — total operating profit mean?
- The total profit earned by the U.S. Pharmaceutical business segment from its core operations before interest and taxes.